<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>This report describes a patient with <z:e sem="disease" ids="C0152267" disease_type="Neoplastic Process" abbrv="LDHL">lymphocyte depleted Hodgkin's disease</z:e> who presented with bone marrow <z:mpath ids='MPATH_58'>aplasia</z:mpath> </plain></SENT>
<SENT sid="1" pm="."><plain>The <z:e sem="disease" ids="C1368107" disease_type="Disease or Syndrome" abbrv="">aplastic marrow</z:e> reverted to <z:mpath ids='MPATH_458'>normal</z:mpath> after initiation of MOPP chemotherapy; however, 4 months after completion of therapy, bone marrow <z:mpath ids='MPATH_58'>aplasia</z:mpath> recurred in the absence of <z:e sem="disease" ids="C0746341" disease_type="Neoplastic Process" abbrv="">recurrent Hodgkin's disease</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>The patient remains free of <z:e sem="disease" ids="C0019829" disease_type="Neoplastic Process" abbrv="hd">Hodgkin's disease</z:e> 34 months after completion of chemotherapy </plain></SENT>
<SENT sid="3" pm="."><plain><z:e sem="disease" ids="C0549539" disease_type="Disease or Syndrome" abbrv="">Bone marrow abnormalities</z:e> in <z:e sem="disease" ids="C0019829" disease_type="Neoplastic Process" abbrv="hd">Hodgkin's disease</z:e> are reviewed and the current understanding of the pathological mechanisms leading to <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo> is discussed </plain></SENT>
</text></document>